WHO Panel To Decide On Covaxin Emergency Use On Wednesday

The Technical Advisory Group of World Health Organisation has sought additional clarifications from Bharat Biotech, the manufacturer of Covaxin, in order to conduct a final Emergency Use Listing risk-benefit assessment for global use of the vaccine.

Related Keywords

India ,Bharat , ,Serum Institute Covishield ,Pfizer ,Bio Serum Institute Of India ,Astrazeneca ,Technical Advisory Group ,Technical Advisory Group For Emergency Use Listing ,World Health Organisation ,Bharat Biotech ,Emergency Use Listing ,Serum Institute ,Covaxin ,Who ,